Metabolic-Fit / 100
MultiMedRx review
Elena Voss is a mother writing for mothers, not a treating clinician, and holds no medical license. Prices and terms come from the company's own published pages. This is background reading, not medical advice.
MultiMedRx publishes no medication price at all. The $100 on its homepage is "the $100 fully refundable consultation fee", and the "$45 to start" is an entry promotion — neither is what the medication costs, and the site never says. It does name its own billing period unusually plainly, though, calling it the "(4-Week monthly) program fee" in the same breath — four weeks, not a month, which is thirteen charges a year rather than twelve. Asked which states it serves, it answers: complete the intake form.
- Confirm HSA / FSA coverage
- Public information reviewed
- Confirm your total cost
MultiMedRx at a glance
- Semaglutide
- No medication price published anywhere
- Tirzepatide
- No medication price published anywhere
- Coverage
- Refuses to publish — "complete the patient intake form"
- Brand-name
- Compounded only
How we scored MultiMedRx
Every factor comes from MultiMedRx's own published pricing, disclosures and oversight, and the six combine into the 33/100 Metabolic-Fit Score on our weighted six-factor framework. Commissions don't change a provider's score.
Cost is unpredictable or sits at the premium end.
No postpartum or breastfeeding framing — a generic weight program.
Thin on the hormonal picture that drives many mothers' weight.
Support is thin once the prescription ships.
Oversight and lab support fall short of the best on our list — the review below says exactly where.
Exit terms are the weak point: lock-in, notice periods, or a cancellation you have to chase.
How we checked this review
It publishes no medication price at all: the $100 on its homepage is a fully refundable consultation fee and the "$45 to start" is an entry promotion, while the program fee that actually covers the medication is described but never stated. Its own FAQ calls that fee the "(4-Week monthly) program fee" — four weeks rather than a calendar month, which is thirteen billing cycles a year — and says it covers medication up to 10ml of tirzepatide or 2.5ml of semaglutide. Asked which states it serves, the site answers that you should complete the intake form. It publishes NPI numbers and two street addresses but names no operating entity.
Pricing
| Medication | Price | Plan |
|---|---|---|
| Compounded semaglutide | $100 | Consultation fee only; no medication price published"Pay the $100 fully refundable consultation fee." This is not a medication price — the site never publishes one. The program fee is said to cover medication "up to 2.5 for Semaglutide" but is not itself stated. |
| Compounded tirzepatide | $100 | Consultation fee only; no medication price publishedSame refundable consultation fee. The program fee is said to cover "up to 10ml for Tirzepatide", again without stating the fee. |
Swipe the table to see plan details →
Many HSA and FSA plans cover GLP-1 telehealth — check yours. These figures are what MultiMedRx's own site disclosed at last review; this market re-prices often, so confirm the current number at the source.
What we like
- The $100 consultation fee is described as fully refundable, and that is stated up front rather than buried
- Says plainly what the program fee covers — medication "up to 10ml for Tirzepatide and 2.5 for Semaglutide"
- "You don't need to sign a long-term contract", with a one-month option available
- Publishes NPI numbers and two street addresses, in Newport Beach and Reno
- Offers metformin, testosterone and hormone replacement alongside the GLP-1s
The caveats
- No medication price appears anywhere on the site — the program fee is described but never stated
- The $100 is a consultation fee and the $45 an entry promotion; neither is a monthly cost
- The billing period is four weeks, not a month — the site's own phrase is "(4-Week monthly) program fee", which is thirteen billing cycles a year
- It will not publish which states it serves: "To find out if we're available in your state, simply complete the patient intake form"
- The medication allowance is capped by volume — 10ml of tirzepatide, 2.5ml of semaglutide — so a higher dose may exhaust it
- No operating entity is named anywhere
Neither visible entry amount is the medication price
MultiMedRx advertises a $100 fully refundable consultation fee and a $45-to-start promotion. Neither is a published semaglutide or tirzepatide medication price. The site describes a continuing program and what it may include, but does not state the program’s complete charge. A reader therefore cannot calculate the treatment budget simply by choosing one of the two entry figures.
The refundable consultation description is useful information to clarify before beginning. Ask how and when a refund can be requested, whether it applies only to the consultation and whether any other service becomes committed at the same time. A stated refund for one fee should not be expanded into a guarantee that every later prescription or program payment is refundable.
The program uses a four-week period
The FAQ calls its recurring charge a “4-Week monthly” program fee. Four weeks is a different interval from a calendar month: a full 52 weeks contains thirteen four-week periods. This affects the annual budget even before the missing program amount is known. Someone comparing a calendar-month subscription should not assume that twelve charges would buy the same treatment duration.
Ask for the exact billing dates, supply period and total fee of the selected program. The site describes a one-month option without requiring a long-term contract, while also offering longer arrangements. Confirm whether “one month” means the same four-week period used in the FAQ and how the chosen option renews. A flexible-sounding program description does not establish the date a cancellation must reach the company.
The included medication has an unclear allowance
The FAQ says the program fee includes medication up to 10 ml for tirzepatide and “2.5” for semaglutide, with the latter amount not clearly explained in the quoted wording. Those statements are not a complete dose-specific supply description. Volume without a confirmed concentration and prescription does not tell a patient how long a particular vial should last.
Have the clinician and dispenser identify the medication, concentration, prescribed dose and quantity. Ask what happens financially if the prescribed treatment needs more than the included allowance. The public language should not be interpreted as unlimited medication at every dose, or as instructions for calculating an individual regimen. The missing program price and the incomplete allowance detail need to be resolved together.
The service offers more than weight treatment
MultiMedRx also lists metformin, testosterone and hormone replacement as possible treatments when clinically appropriate. That breadth may be convenient for someone considering several health concerns, but it does not demonstrate that every weight-loss consultation includes hormone testing or specialist care. Each proposed treatment should have its own clinical explanation and cost.
The site publishes NPI numbers and street addresses in Newport Beach and Reno. Those disclosures are useful starting points for identifying the practice, but the public policy material does not clearly name an operating entity. An address or NPI listing should not be treated as a substitute for knowing which professional will provide the actual consultation and which company will collect the continuing program fee.
State availability is another unanswered prepayment question
When asked which states it serves, MultiMedRx directs visitors to complete the intake form. That leaves a reader unable to establish the service area from a public list. Confirm availability for the intended medication at your address before assuming that an introductory consultation leads to dispensing.
The decision is clearest once MultiMedRx supplies a complete four-week quote, the precise medication allowance and the terms for renewal or stopping. The entry consultation may be affordable, but the ongoing amount remains unknown. Someone who needs a fully visible treatment budget before sharing medical information has a reasonable basis to compare more transparent offers first. The $45 promotion and refundable $100 visit should remain labeled as entry charges, not recast as the cost of a month’s medication.
The bottom line for mothers
Best for: Hard to say without a medication price, which the site does not provide.
Alternatives to MultiMedRx
These are partners — we may be paid if you sign up through these links. The full list has every provider we cover, partner or not.
- Visit CoreAge Rx86
Metabolic-Fit / 100
CoreAge RxFeatured partnerCoreAge's officially linked public offer advertises compounded semaglutide at $79/month and tirzepatide at $129/month across doses, with care and overnight shipping included. It describes one-time purchases without a required subscription. Main navigation still shows semaglutide from $99; confirm your prescription quantity and total, and read the refund limits before paying.
- Visit MadeMed46
Metabolic-Fit / 100
A flat $239/mo semaglutide, $399/mo tirzepatide with one-click cancellation and a free L-Carnitine add-on at every dose — but it's only licensed in 23 states, and most of the country's biggest population centers aren't on the list.
- Visit Collective40
Metabolic-Fit / 100
Compounded semaglutide at $59 per month and tirzepatide at $69, with a separate required $199 annual membership. Twelve medication charges plus membership total $907 or $1,027 in the first year. A 21-day membership trial precedes the annual charge; it does not promise free medication, and paid membership fees are non-refundable. The program lists 44 states, excluding Alabama, California, Louisiana, Massachusetts, Mississippi and Washington. Confirm the dispensing pharmacy and the cancellation deadlines before joining.
Providers like MultiMedRx
Keep comparing MultiMedRx
Head-to-head & alternatives
Ranked boards
- Best GLP-1 for women
- Best GLP-1 for PCOS & insulin resistance
- Best GLP-1 for perimenopause
- Best GLP-1 while breastfeeding (safety-first)
- Cheapest GLP-1 programs
- Compounded tirzepatide providers
- Cheapest tirzepatide online
- Cheapest semaglutide online
- Where to get Zepbound online
- Semaglutide vs tirzepatide: which is right for you
MultiMedRx, answered
- How much does MultiMedRx cost?
- MultiMedRx does not establish a comparable recurring monthly medication rate. Published pricing: No medication price published anywhere for semaglutide; No medication price published anywhere for tirzepatide. Ask for the complete charge, supply period and renewal terms before committing.
- Is MultiMedRx safe to use while breastfeeding?
- Pregnancy is the clear line: no GLP-1 is established as safe while you are pregnant. If you are nursing, the Wegovy injection, Ozempic, Zepbound and Mounjaro labels say there is little or no data on the drug in breast milk, and they leave it to you and your clinician to weigh the benefits of breastfeeding against your need for treatment. Compounded versions carry no label of their own, so that conversation matters more, not less. MultiMedRx is not an exception to any of that — settle the timing with your own clinician.
- Does MultiMedRx offer both semaglutide and tirzepatide?
- Yes — MultiMedRx offers both molecules. Tirzepatide's dual GIP/GLP-1 action is often preferred where insulin resistance drives weight, which matters for PCOS and after gestational diabetes.
- How does MultiMedRx score for mothers?
- MultiMedRx scores 33/100 on our Metabolic-Fit Score, a weighted read of six things mothers actually have to care about. CoreAge Rx, a featured partner, is worth a side-by-side look.
Pricing, states and verification reflect MultiMedRx's public disclosures at last review; the Metabolic-Fit Score is our editorial judgment per the published methodology. This is background reading, not medical advice — GLP-1 medications are not established as safe in pregnancy or breastfeeding. See our medical disclaimer and how we're funded.